Evaluation of TRAIL receptor 1 (DR4) Polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
about
Evaluation of TRAIL receptor 1 (DR4) Polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Evaluation of TRAIL receptor 1 ...... s of hepatocellular carcinoma.
@en
type
label
Evaluation of TRAIL receptor 1 ...... s of hepatocellular carcinoma.
@en
prefLabel
Evaluation of TRAIL receptor 1 ...... s of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Evaluation of TRAIL receptor 1 ...... s of hepatocellular carcinoma.
@en
P2093
Ahmed ElSayed ElTaweel
Manal Mohamed Kamal
Naglaa Fathy Alsalawy
Rania Kamal Darwish
Tamer Mahmoud Elbaz
P2860
P356
10.1002/JMV.24964
P577
2017-10-03T00:00:00Z